OTC Markets OTCQX - Delayed Quote USD
Enzon Pharmaceuticals, Inc. (ENZN)
0.0900
0.0000
(0.00%)
At close: May 9 at 4:00:00 PM EDT
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Richard L. Feinstein CPA | CEO, CFO & Secretary | 226.93k | -- | 1943 |
Enzon Pharmaceuticals, Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
Description
Enzon Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the sale of its patented drug product, PegIntron. The company was formerly known as Enzon, Inc and changed its name to Enzon Pharmaceuticals, Inc. in December 2002. Enzon Pharmaceuticals, Inc. was incorporated in 1981 and is headquartered in Cranford, New Jersey.
Corporate Governance
Enzon Pharmaceuticals, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
August 6, 2025 at 8:00 PM UTC - August 11, 2025 at 8:00 PM UTC
Enzon Pharmaceuticals, Inc. Earnings Date
Recent Events
Related Tickers
IMUC EOM Pharmaceuticals Holdings, Inc.
0.1050
0.00%
PHVS Pharvaris N.V.
16.99
-0.29%
EXOZ eXoZymes, Inc.
13.01
+2.68%
GTBP GT Biopharma, Inc.
2.2700
-2.58%
NERV Minerva Neurosciences, Inc.
1.6100
-0.62%
UPB Upstream Bio, Inc.
8.82
-0.23%
SNSE Sensei Biotherapeutics, Inc.
0.3600
-4.41%
CLGN CollPlant Biotechnologies Ltd.
1.8200
-0.55%
AURA Aura Biosciences, Inc.
5.23
-9.83%
VRAX Virax Biolabs Group Limited
1.0500
-0.94%